Warner; Steven L.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Warner; Steven L..The latest application filed is for "combination therapies for treatment of cancer".

Company Profile

31.37.58

Warner; Steven L. - Sandy UT
Warner; Steven L. - Cambridge MA
Warner; Steven L. - Lehi UT
Warner; Steven L. - Mesa AZ
Warner; Steven L. - Tucson AZ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
AXL kinase inhibitors and use of the same Grant 11,400,091 - Siddiqui-Jain , et al. August 2, 2	2022-08-02
Combination Therapies For Treatment Of Cancer App 20210228582 - Bearss; David J. ; et al.	2021-07-29
Axl Kinase Inhibitors And Use Of The Same App 20210205304 - Siddiqui-Jain; Adam ; et al.	2021-07-08
Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same Grant 11,040,038 - Warner , et al. June 22, 2	2021-06-22
Materials And Methods For Treating Cancer App 20210145830 - Kenderian; Saad J. ; et al.	2021-05-20
Pim Kinase Inhibitors For Treatment Of Myeloproliferative Neoplasms And Fibrosis Associated With Cancer App 20210113562 - FOULKS; Jason Marc ; et al.	2021-04-22
Jak2 And Alk2 Inhibitors And Methods For Their Use App 20210070715 - Mollard; Alexis ; et al.	2021-03-11
Predicting Response To Alvocidib By Mitochondrial Profiling App 20210052568 - WARNER; Steven L. ; et al.	2021-02-25
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof App 20210000825 - Siddiqui-Jain; Adam ; et al.	2021-01-07
Combination therapies for treatment of cancer Grant 10,835,537 - Bearss , et al. November 17, 2	2020-11-17
Formulations Comprising Heterocyclic Protein Kinase Inhibitors App 20200338076 - WARNER; Steven L. ; et al.	2020-10-29
Alk5 Inhibitors For Treating Myelodysplastic Syndrome App 20200323851 - BEARSS; David J. ; et al.	2020-10-15
Methods To Target Transcriptional Control At Super-enhancer Regions App 20200316084 - WARNER; Steven L. ; et al.	2020-10-08
Compositions Comprising Pkm2 Modulators And Methods Of Treatment Using The Same App 20200297698 - WARNER; Steven L. ; et al.	2020-09-24
Methods For Treating Castration-resistant And Castration-sensitive Prostate Cancer App 20200281949 - WARNER; Steven L. ; et al.	2020-09-10
Treatment Regimen For Cancers That Are Insensitive To Bcl-2 Inhibitors Using The Mcl-1 Inhibitor Alvocidib App 20200276215 - BEARSS; David J. ; et al.	2020-09-03
Cyclin-dependent Kinase Inhibitors In Combination With Anthracyclines For Treatment Of Cancer App 20200276174 - BEARSS; David J. ; et al.	2020-09-03
JAK1 and ALK2 inhibitors and methods for their use Grant 10,752,594 - Mollard , et al. A	2020-08-25
Pkm2 Activators In Combination With Reactive Oxygen Species For Treatment Of Cancer App 20200237766 - SIDDIQUI-JAIN; Adam ; et al.	2020-07-30
Combination Therapies For Treatment Of Cancer App 20200215071 - Bearss; David J. ; et al.	2020-07-09
Profiling Peptides And Methods For Sensitivity Profiling App 20200200737 - BEARSS; David J. ; et al.	2020-06-25
Combination therapies for treatment of cancer Grant 10,682,356 - Bearss , et al.	2020-06-16
Predicting response to alvocidib by mitochondrial profiling Grant 10,624,880 - Warner , et al.	2020-04-21
Methods For Treating Diseases Associated With Abnormal Acvr1 Expression And Acvr1 Inhibitors For Use In The Same App 20200085823 - Warner; Steven L. ; et al.	2020-03-19
Combination therapies for treatment of cancer Grant 10,568,887 - Bearss , et al. Feb	2020-02-25
Combination Therapies For Treatment Of Cancer App 20200054642 - Bearss; David J. ; et al.	2020-02-20
Cyclin-dependent Kinase Inhibitors In Combination With Anthracyclines For Treatment Of Cancer App 20190314357 - Bearss; David J. ; et al.	2019-10-17
Profiling peptides and methods for sensitivity profiling Grant 10,422,788 - Bearss , et al. Sept	2019-09-24
Predicting Response To Alvocidib By Mitochondrial Profiling App 20190282557 - Warner; Steven L. ; et al.	2019-09-19
Predicting response to alvocidib by mitochondrial profiling Grant 10,357,488 - Warner , et al. July 23, 2	2019-07-23
Profiling Peptides And Methods For Sensitivity Profiling App 20190178873 - BEARSS; David J. ; et al.	2019-06-13
Jak2 And Alk2 Inhibitors And Methods For Their Use App 20190119221 - Mollard; Alexis ; et al.	2019-04-25
Profiling peptides and methods for sensitivity profiling Grant 10,267,787 - Bearss , et al.	2019-04-23
JAK2 and ALK2 inhibitors and methods for their use Grant 10,202,356 - Mollard , et al. Feb	2019-02-12
Predicting Response To Alvocidib By Mitochondrial Profiling App 20190030017 - Warner; Steven L. ; et al.	2019-01-31
Profiling peptides and methods for sensitivity profiling Grant 10,132,797 - Bearss , et al. November 20, 2	2018-11-20
Profiling Peptides And Methods For Sensitivity Profiling App 20180299432 - Bearss; David J. ; et al.	2018-10-18
Methods To Target Transcriptional Control At Super-enhancer Regions App 20180280407 - Warner; Steven L. ; et al.	2018-10-04
Combination Therapies For Treatment Of Cancer App 20180256580 - Bearss; David J. ; et al.	2018-09-13
Profiling Peptides And Methods For Sensitivity Profiling App 20180172673 - Bearss; David J. ; et al.	2018-06-21
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors App 20180134719 - Vankayalapati; Hariprasad ; et al.	2018-05-17
Predicting response to alvocidib by mitochondrial profiling Grant 9,901,574 - Warner , et al. February 27, 2	2018-02-27
Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors Grant 9,828,376 - Vankayalapati , et al. November 28, 2	2017-11-28
Multiple kinase pathway inhibitors Grant 9,714,247 - Zeng , et al. July 25, 2	2017-07-25
Substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors Grant 9,642,857 - Vankayalapati , et al. May 9, 2	2017-05-09
Multiple Kinase Pathway Inhibitors App 20170107215 - Zeng; Qingping ; et al.	2017-04-20
Substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors Grant 9,555,024 - Vankayalapati , et al. January 31, 2	2017-01-31
Multiple kinase pathway inhibitors Grant 9,493,454 - Zeng , et al. November 15, 2	2016-11-15
Predicting Response To Alvocidib By Mitochondrial Profiling App 20160303101 - Warner; Steven L. ; et al.	2016-10-20
Jak2 And Alk2 Inhibitors And Methods For Their Use App 20160214944 - MOLLARD; Alexis ; et al.	2016-07-28
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide Analogs As Histone Demethylase Inhibitors App 20160120875 - Vankayalapati; Hariprasad ; et al.	2016-05-05
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors Grant 9,296,703 - Vankayalapati , et al. March 29, 2	2016-03-29
Substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors Grant 9,266,838 - Vankayalapati , et al. February 23, 2	2016-02-23
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors App 20160046586 - Bearss; David J. ; et al.	2016-02-18
Substituted N-(3-(Pyrimidin-4-YL)Phenyl)Acrylamide Analogs as Tyrosine Receptor Kinase BTK Inhibitors App 20150368208 - Vankayalapati; Hariprasad ; et al.	2015-12-24
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors Grant 9,206,176 - Bearss , et al. December 8, 2	2015-12-08
Multiple Kinase Pathway Inhibitors App 20150266870 - Zeng; Qingping ; et al.	2015-09-24
Substituted N-(3-pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors App 20150252048 - Vankayalapati; Hariprasad ; et al.	2015-09-10
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide Analogs As Histone Demethylase Inhibitors App 20150150864 - Vankayalapati; Hariprasad ; et al.	2015-06-04
Protein kinase inhibitors Grant 8,999,988 - Hurley , et al. April 7, 2	2015-04-07
Substituted (E)-N'-(1-phenylethylidene)benzohydrazide analogs as histone demethylase inhibitors Grant 8,987,335 - Vankayalapati , et al. March 24, 2	2015-03-24
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors App 20150018349 - Bearss; David J. ; et al.	2015-01-15
Substituted N-phenylpyrimidin-2-amine analogs as inhibitors of the Axl kinase Grant 8,901,120 - Bearss , et al. December 2, 2	2014-12-02
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide Analogs As Histone Demethylase Inhibitors App 20140163017 - Vankayalapati; Hariprasad ; et al.	2014-06-12
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase BTK inhibitors Grant 8,703,767 - Bearss , et al. April 22, 2	2014-04-22
Substituted (e)-n'-(1-phenylethylidene)benzohydrazide Analogs As Histone Demethylase Inhibitors App 20140094445 - Vakayalapati; Hariprasad ; et al.	2014-04-03
Protein Kinase Inhibitors App 20130302303 - Hurley; Laurence H. ; et al.	2013-11-14
Substituted 3-(1H-benzo[d]imidazol-2-yl)-1H-indazole analogs as inhibitors of the PDK1 kinase Grant 8,569,511 - Bearss , et al. October 29, 2	2013-10-29
Substituted tricyclic compounds as protein kinase inhibitors Grant 8,552,018 - Hurley , et al. October 8, 2	2013-10-08
Substituted N-(3-(pyrimidin-4-yl)phenyl)acrylamide Analogs As Tyrosine Receptor Kinase Btk Inhibitors App 20130059847 - Bearss; David J. ; et al.	2013-03-07
Substituted N-phenylpyrimidin-2-amine Analogs As Inhibitors Of The Axl Kinase App 20120283261 - Bearss; David J. ; et al.	2012-11-08
Substituted 3-(1h-benzo[d]imidazol-2-yl)-1h-indazole Analogs As Inhibitors Of The Pdk1 Kinase App 20120277229 - Bearss; David J. ; et al.	2012-11-01
Protein Kinase Inhibitors App 20110212929 - Hurley; Laurence H. ; et al.	2011-09-01
Protein Kinase Inhibitors App 20090143399 - Hurley; Laurence H. ; et al.	2009-06-04
Protein Kinase Inhibitors App 20090099165 - Hurley; Laurence H. ; et al.	2009-04-16
Protein Kinase Inhibitors App 20080051414 - Hurley; Laurence H. ; et al.	2008-02-28
Substituted tricyclic compounds as protein kinase inhibitors Grant 7,335,662 - Hurley , et al. February 26, 2	2008-02-26
Substituted tricyclic compound as protein kinase inhibitors Grant 7,326,713 - Hurley , et al. February 5, 2	2008-02-05
Substituted tricyclic compounds as protein kinase inhibitors Grant 7,326,712 - Hurley , et al. February 5, 2	2008-02-05
Substituted tricyclic compounds as protein kinase inhibitors Grant 7,312,226 - Hurley , et al. December 25, 2	2007-12-25
Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer App 20070026398 - Farnsworth; AmandaL ; et al.	2007-02-01
Protein kinase inhibitors App 20050277658 - Hurley, Laurence H. ; et al.	2005-12-15
Protein kinase inhibitors App 20050239793 - Hurley, Laurence H. ; et al.	2005-10-27
Protein kinase inhibitors App 20050239794 - Hurley, Laurence H. ; et al.	2005-10-27
Protein kinase inhibitors App 20050227992 - Hurley, Laurence H. ; et al.	2005-10-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.